Andrew Epstein
Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1649214800
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $87,042 of the $108,585 with a category attached, or 80.2%. 11 manufacturers reported payments, led by Abbott at 48.1% of the total. Reporting peaked in 2019 at $51,791 and has fallen 83.4% since, to $8,602 in 2025.
Across 143 payments — averaging $759.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$52K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$26K
- Boston Scientific$23K
- Medtronic$7K
- Altathera Pharmaceuticals LLC$500
- Biotronik Inc.$262
- plus $212 from 5 others
Across 5 payments — averaging $885.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$4K
What the payments were for
- Consulting fees$87,04280%
- Speaking & faculty fees$13,00012%
- Travel & lodging$5,3175%
- Food & beverage$3,2273%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 77 | $52,188 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $25,609 |
| Boston Scientific | 28 | $23,169 |
| Medtronic(2 entities) | 16 | $6,646 |
| Altathera Pharmaceuticals LLC | 1 | $500 |
| Biotronik Inc. | 4 | $262 |
| Biosense Webster, Inc. | 1 | $74 |
| Merck | 1 | $64 |
| Akcea Therapeutics, Inc. | 1 | $36 |
| Cardiva Medical, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$25,404
- CLINICAL TRIAL PRODUCT$22,592
- ENSITE PRECISION$12,350
- Optisure Defibrillation ICD Lead$11,250
- HeartMate$7,650
- EnSite Precision Cardiac Mapping System$7,500
- Quartet CRT Lead$3,600
- Merlin Connectivity and Remote$2,500
- Ensite Cardiac Mapping System$2,315
- Durata Defibrillation ICD Lead$1,575
- Quadra Allure MP RF CRT Pacemkr$1,000
- Sotalol Hydrochloride$500
- Confirm Rx$463
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$256
- ENSITE$188
- GENERAL - THERAPIES$149
- Watchman$130
- AVEIR$121
How this compares
$108,585 in reported general payments places this provider in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisinopril | 11 | $0 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Philadelphia
- Fermin GarciaPhiladelphia$684K
- Ralph VerdinoPhiladelphia$682K
- Pasquale SantangeliPhiladelphia$581K
- Francis MarchlinskiPhiladelphia$469K
- Joshua CooperPhiladelphia$405K
- Timothy MarkmanPhiladelphia$402K
- David CallansPhiladelphia$350K
- Robert SchallerPhiladelphia$333K
- Matthew HymanPhiladelphia$294K
- David FrankelPhiladelphia$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.